Tic-Disorder Clinical Trial
Official title:
Randomized Control Trial on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents - a Comparison With Resource Activation Treatment
Verified date | March 2017 |
Source | University of Cologne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme compared to an alternative treatment which aims at the activation of resources in children and adolescents aged 8 to 18 years with tic disorders.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | September 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 18 Years |
Eligibility |
Inclusion Criteria: - 8-18 years - Diagnosis of chronic motor or vocal Tic (F95.1) or Tourette-Syndrome (F95.2) - YGTSS total score F95.2>13, F95.1>9 - Tics are the main problems - Intelligence IQ>80 - If medication, then has been stable for at least one months in medicated patients - No change in medication treatment is planned - Ability to participate in weekly outpatient treatment - Acceptance of randomization Exclusion Criteria: Diagnosis of Autism Spectrum Disorder or Psychosis Parallel continuous psychotherapy of tics or comorbid - |
Country | Name | City | State |
---|---|---|---|
Germany | University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy | Cologne |
Lead Sponsor | Collaborator |
---|---|
University of Cologne |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in Symptom Checklist for Tic-Symptoms (FBB-TIC, parent rating) at week 8, 16 and 24 | The FBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents | eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3) | |
Primary | Change in Quality of Life (Tic-HRQoL-FBB)(parent rating) | The Tic-HRQoL-FBB is used to assess impairment and quality of life through tic symptoms and other comorbid symptoms rated by parents | eight weeks (T1) and twenty-four weeks (T3) | |
Secondary | Change in Symptom Checklist for Tic-Symptoms (FBB-/SBB-TIC), Teacher-/self-rating | The SBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents | eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3) | |
Secondary | Change in Symptom Checklist for Tic-Symptoms, clinical rating | The Checklist is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by clinicians | eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3) | |
Secondary | Change of comorbid ADHD Symptoms (FBB/SBB-ADHD), parent, teacher and self-rating | The Symptom Checklist for Attention Deficit/Hyperactivity Disorder (FBB-/SBB-ADHS) assess all symptom criteria according to DSM IV and ICD-10. | eight weeks (T1), and 24 weeks (T3) | |
Secondary | Change of comorbid OCD Symptoms (ZWIK-E), parent-rating | The ZWIK assess OCD criteria. | eight weeks (T1), and 24 weeks (T3) | |
Secondary | Change of comorbid Symptoms (CBCL/TRF/YSR), parent-/teacher-/self-rating | The CBCL, TRF and YSR assess a variation of different criteria. | eight weeks (T1), and 24 weeks (T3) | |
Secondary | Change in self-esteem (Harter-Scale-SBB)(self rating) | The Harter-Scale is used to assess self-esteem | eight weeks (T1), and 24 weeks (T3) | |
Secondary | Change in Tic-Symptoms (YGTSS-TIC), overall score | The YGTSS is used to assess Tic-Symptoms in a semi structured interview with parents and patients | eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3) | |
Secondary | Change in Tic-Symptoms (observation) | Tic symptoms are observed through video tapes and are rated through clinicians. | 24 weeks (weekly assessment) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02190383 -
Efficacy of a Habit Reversal Treatment on Tic-symptoms
|
N/A | |
Recruiting |
NCT02190370 -
Efficacy of a Resources Activation Treatment on Tic-symptoms
|
N/A |